Onset of action of house dust mite sublingual immunotherapy tablet (SLIT-T) using an environmental exposure chamber

被引:0
|
作者
Horak, F. [1 ]
Maloney, J. [2 ]
Nelson, S. H. [3 ]
Bernstein, D., I [4 ]
Li, Z. [2 ]
Zieglmayer, P. [1 ]
Zieglmayer, R. [1 ]
Lemell, P. [1 ]
Nolte, H. [2 ]
机构
[1] Vienna Challenge Chamber, Vienna, Austria
[2] Merck, Whitehouse Stn, NJ USA
[3] Natl Jewish Hlth, Denver, CO USA
[4] Bernstein Allergy Grp, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
1778
引用
收藏
页码:610 / 610
页数:1
相关论文
共 50 条
  • [21] SQ HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IS WELL TOLERATED IN SUBJECTS WITH ALLERGIC ASTHMA
    Maloney, J.
    Hulstrom, V.
    Smith, I. Mosbech
    Nolte, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S59 - S59
  • [22] HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET FOR ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS IN MONOSENSITIZED AND POLYSENSITIZED CHILDREN
    Nolte, H.
    Caimmi, D.
    Pfaar, O.
    Bennett, J. Kress
    Foss-Skiftesvik, M.
    Schuster, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
  • [23] Safety of Year-Round Initiation with SQ House Dust Mite Sublingual Immunotherapy Tablet
    Nolte, Hendrik
    Bernstein, David I.
    Kleine-Tebbe, Joerg R.
    Fejerskov, Peter A.
    Li, Qing
    Lu, Susan
    McGratty, Megan
    Nelson, Harold S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB61 - AB61
  • [24] Onset of Action of Sublingual Tablets of House Dust Mite Allergen Extracts in Adults
    Demoly, Pascal M.
    Bergmann, Karl-Christian
    Melac, Michel
    Helene Nguyen
    Frereux, Marine
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB37 - AB37
  • [25] Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
    Hoshino, Makoto
    Akitsu, Kenta
    Kubota, Kengo
    Ohtawa, Junichi
    ALLERGOLOGY INTERNATIONAL, 2022, 71 (04) : 490 - 497
  • [26] The safety trial of sequential sublingual immunotherapy with Japanese cedar droplet and house dust mite tablet
    Matsuoka, T.
    Kuroda, Y.
    Igarashi, S.
    Fukano, C.
    Natsui, K.
    Ohashi-Doi, K.
    Masuyama, K.
    ALLERGY, 2018, 73 : 483 - 483
  • [27] SAFETY OF THE HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN A PEDIATRIC ALLERGIC RHINITIS/RHINOCONJUNCTIVITIS TRIAL
    Caimmi, D.
    Nolte, H.
    Pfaar, O.
    Foss-Skiftesvik, M.
    Osterdal, A.
    Schuster, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S18 - S18
  • [28] Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children
    Masuyama, Keisuke
    Okamoto, Yoshitaka
    Okamiya, Kazuhiro
    Azuma, Ryuji
    Fujinami, Toshiaki
    Riis, Bente
    Ohashi-Doi, Katsuyo
    Natsui, Kensuke
    Imai, Toru
    Okubo, Kimihiro
    ALLERGY, 2018, 73 (12) : 2352 - 2363
  • [29] Efficacy of 12 SQ House Dust Mite Sublingual Immunotherapy Tablet in Monosensitized and Polysensitized Subjects
    Nelson, Harold S.
    Bernstein, David I.
    Kleine-Tebbe, Joerg R.
    Li, Ziliang
    Lu, Susan
    Nolte, Hendrik
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB192 - AB192
  • [30] SAFETY OF FIRST DOSE OF SQ HOUSE DUST MITE SUBLINGUAL IMMUNOTHERAPY TABLET IN CLINICAL TRIALS
    Bernstein, D.
    Maloney, J.
    Smith, I. Mosbech
    Nolte, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (05) : S59 - S59